South Dakota Investment Council Has $20.58 Million Position in Bath & Body Works, Inc. $BBWI

South Dakota Investment Council lifted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 65.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 798,796 shares of the company’s stock after buying an additional 314,614 shares during the period. South Dakota Investment Council’s holdings in Bath & Body Works were worth $20,577,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. JPMorgan Chase & Co. lifted its stake in Bath & Body Works by 11.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock worth $212,120,000 after acquiring an additional 733,000 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Bath & Body Works by 5.8% during the second quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock worth $171,904,000 after purchasing an additional 315,738 shares during the period. Cooper Creek Partners Management LLC grew its position in Bath & Body Works by 42.7% during the second quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after purchasing an additional 1,619,276 shares in the last quarter. American Century Companies Inc. increased its stake in Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after buying an additional 4,949,796 shares during the period. Finally, AQR Capital Management LLC lifted its position in Bath & Body Works by 5.3% in the 2nd quarter. AQR Capital Management LLC now owns 4,203,326 shares of the company’s stock worth $125,322,000 after buying an additional 210,153 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Down 3.3%

Shares of Bath & Body Works stock opened at $22.02 on Tuesday. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $36.89. The stock has a 50 day moving average price of $22.19 and a two-hundred day moving average price of $23.63. The stock has a market capitalization of $4.51 billion, a P/E ratio of 6.78, a PEG ratio of 1.00 and a beta of 1.54.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Investors of record on Friday, February 20th will be paid a $0.20 dividend. The ex-dividend date is Friday, February 20th. This represents a $0.80 dividend on an annualized basis and a yield of 3.6%. Bath & Body Works’s dividend payout ratio (DPR) is presently 24.62%.

Key Stories Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Spring product collaboration (PEEPS) is drawing shopper interest, a potential boost to seasonal sales and merchandising momentum. PEEPS Collaboration / Valuation Check
• Positive Sentiment: Two small analyst actions raised targets: Barclays lifted its target to $21 (equal-weight) and another outlet reported a $23 target — incremental support but not strong bullish conviction. Barclays Price Target Note Price Target Raised to $23
• Neutral Sentiment: Investors are awaiting upcoming earnings and guidance; previews note key metrics to watch (same-store sales, margin trends, and inventory) that will drive near-term sentiment. Earnings uncertainty can amplify moves from other headlines. Earnings Preview
• Negative Sentiment: A wave of securities‑class‑action filings and multiple law‑firm notices seek lead plaintiffs for alleged misstatements covering June 2024–Nov 2025—heightening legal risk and potential future liabilities and distracting management. (Representative notices shown.) Robbins LLP Notice Levi & Korsinsky Filing
• Negative Sentiment: A sizeable institutional stake (~$129M) was liquidated as the firm cut its outlook, signaling reduced institutional conviction and adding selling pressure into the quarter. Stake Liquidation Report

Analyst Ratings Changes

A number of equities analysts have recently weighed in on BBWI shares. Barclays upped their price target on shares of Bath & Body Works from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Monday. Telsey Advisory Group lifted their price target on Bath & Body Works from $17.00 to $23.00 and gave the company a “market perform” rating in a report on Friday. UBS Group boosted their price target on Bath & Body Works from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, February 23rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a research report on Wednesday, January 21st. Finally, Bank of America set a $26.00 target price on shares of Bath & Body Works in a research note on Monday, November 24th. Three research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $23.79.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.